Disease Areas of Collaborative Focus


Diet-Induced NASH (AMLN)

Assess your experimental materials for efficacy and mechanism of action in BioModels’ Diet-Induced NASH model. Nonalcoholic steatohepatitis (NASH), the most severe form of nonalcoholic fatty liver disease (NAFLD), is a condition in which the liver builds up excessive fat deposits, potentially resulting in fibrosis, cirrhosis, and hepatocellular carcinoma.

Experimental endpoints for these models include:

  • Weight Change
  • Bone Densitometry and Body Composition (DEXA)
  • Blood Glucose and Insulin
  • Histopathology
  • Custom Assays and Endpoints

Study Models

Diet-Induced NASH (AMLN/GAN)

Diet-Induced NASH (AMLN/GAN)

Daniel Lichtman

Managing Partner